Aug 11th, 2014
An easier colorectal screening method may be reimbursed by Centers for Medicare & Medicaid Services (CMS) related programs if support for a proposed decision memo succeeds. CMS is proposing coverage of the Cologuard™ DNA stool test once every three years for beneficiaries who meet particular criteria. Cologuard was recently approved by the Food and Drug ...
In Billing
Aug 9th, 2012
In a final decision memo, the Centers for Medicare & Medicare Services (CMS) says there is insufficient evidence that autologous platelet-rich plasma (PRP) improves health outcomes in individuals with chronic diabetic, pressure, and/or venous wounds. PRP used to treat chronic non-healing diabetic, pressure, and/or venous wounds may be covered under Medicare only when the beneficiary ...
In Billing
Jun 18th, 2012
Transcutaneous electrical nerve stimulation (TENS) for chronic low back pain (CLBP) is not reasonable and necessary, the Centers for Medicare & Medicaid Services (CMS) said in a final decision memo released June 8. CMS first announced it was reconsidering coverage of TENS for CLBP in a proposed decision memo published March 13. Throwing advocates of ...